This inventor holds 2 USPTO granted patents. Top assignees: Laboratories Knoll, S.a., Laboratorios Made, S.a.. Active years: 1980-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1993
Title: Antonio M Sanz: Innovator in Leukemia Treatment
Introduction
Antonio M Sanz is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medical treatments, particularly in the area of leukemia and solid tumors. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents is a method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide, which is recognized as an effective agent for the treatment of leukemias and solid tumors. Another patent involves the preparation of N(Aminoalkyl)-naphthalimides and their derivatives, where N-substituted-3-substituted naphthalimides are synthesized by reacting 3-substituted naphthalic acid with a compound that has a primary amino group. These naphthalimides are noted for their cytotoxic properties.
Career Highlights
Throughout his career, Antonio has worked with various companies, including Laboratorios Made, S.A. and Laboratories Knoll, S.A. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Antonio has collaborated with several professionals in his field, including Miguel Fernandez Brana and Rafael P Alvarez-Ossorio. Their joint efforts have furthered advancements in medical treatments.
Conclusion
Antonio M Sanz is a distinguished inventor whose work in leukemia treatment showcases his dedication to medical innovation. His patents reflect a commitment to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile